Latest Press Release on flu vaccine

Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
BERKELEY, CA -- 02/08/10 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today initiation of a large-scale Phase 3 trial designed to demonstrate the lot-to-lot consistency of commercial vaccine and to complete the safety database for H..


Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 an


NanoBio Awarded Key Patent Covering Vaccine and Anti-Infective Product Platforms
ANN ARBOR, Mich. - NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company’s lead anti-infective and vaccine product candidates.


Sinovac Announces Closing of Common Share Offering
BEIJING, Feb. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, announced today that its prev...


Inovio Biomedical to Present at BIO CEO & Investor Conference
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, President and CEO, will present at the 12th Annual BIO CEO & Investor Conference on Monday, February 8th, at 11:30 a.m. ET


Nation's First 'Cocoon Strategy' Vaccination Program Delivers 10,000th Immunization
HOUSTON, Feb. 3 /PRNewswire/ -- Physicians from the Center for Vaccine Awareness and Research at Texas Children's Hospital reported that 10,000 Tdap immunizat...


Immunovaccine Provides Corporate Update
HALIFAX, NOVA SCOTIA -- 02/04/10 -- Immunovaccine Inc. (TSX VENTURE: IMV) a clinical-stage vaccine development Company, is pleased to provide an update on certain corporate activities. Phase I Clinical Trial Update As announced on December 9,..


Research and Markets: China Disposable Vaccine Syringe Market Analysis 2009 is Vital Reading for those in the Medical and Pharmaceutical Industry
DUBLIN - Research and Markets(http://www.researchandmarkets.com/research/ed1690/china_disposable_v) has announced the addition of the China Disposable Vaccine Syringe Market Analysis 2009 report to their offering. China disposable vaccine syringe market analysis is an inv


NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
ROCKVILLE, Md., Feb. 5 -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax ...





 
 

Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark

 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.